The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety run-in phase of the multi-epitope HER2 peptide vaccine in combination with trastuzumab emtansine in HER2-positive breast cancer with residual disease after neoadjuvant chemotherapy.
 
Saranya Chumsri
Consulting or Advisory Role - Axiom Biotechnologies; Cardinal Health; Cepton Strategies; Dedham Group; Eisai; Equinox Group; Eradigm Consulting; Novartis; Puma Biotechnology; Seagen
Research Funding - Briacell; GlaxoSmithKline; Merck; Novartis; Pfizer; Salix
 
Sharmila Giri
No Relationships to Disclose
 
Andrew Ness
Employment - Mayo Clinic
 
David W. Hillman
No Relationships to Disclose
 
Nadine Norton
No Relationships to Disclose
 
Davitte Cogen
No Relationships to Disclose
 
Edward Famularo
No Relationships to Disclose
 
Brianna Richardson
No Relationships to Disclose
 
Brian Necela
No Relationships to Disclose
 
Aziza Nassar
No Relationships to Disclose
 
Donald W. Northfelt
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Pooja Prem Advani
Stock and Other Ownership Interests - Abbvie (I); Alpha2 Pharmaceuticals (I); NanoString Technologies (I); Sorrento Therapeutics (I)
Honoraria - Ascentage Pharma Group (I); AstraZeneca (I)
Consulting or Advisory Role - Ascentage Pharma (I); AstraZeneca (I); BMS (I); Puma Biotechnology
Research Funding - Agendia; Ascentage Pharma (I); AstraZeneca (Inst); Atossa Therapeutics (Inst); Ayala Pharmaceuticals (Inst); Bristol Myer Squibb (I); Caris Life Sciences (Inst); Genentech/Roche; Gilead Sciences (Inst); Seagan (Inst)
Patents, Royalties, Other Intellectual Property - patent pending on PCT-US2020-067237 (cancer vaccine platform) (I)
Travel, Accommodations, Expenses - Caris Life Sciences; Tempus (I)
 
Rohit Rao
No Relationships to Disclose
 
Kostandinos Sideras
No Relationships to Disclose
 
Alvaro Moreno-Aspitia
Stock and Other Ownership Interests - Merrimack
Research Funding - Genentech (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from the development of a xenograft model. Royalties were assigned to go to my institution and not personally
 
Brenda Ernst
No Relationships to Disclose
 
Kathryn Jean Ruddy
Research Funding - Medtronic (I)
Patents, Royalties, Other Intellectual Property - Spouse and Mayo Clinic have filed patents related to the application of artificial intelligence to the electrocardiogram for diagnosis and risk stratification. (I)
 
Matthew P. Goetz
Consulting or Advisory Role - ARC Therapeutics (Inst); AstraZeneca (Inst); BioTheryX; Blueprint Medicines (Inst); Engage Health Media (Inst); Genzyme (Inst); Laekna Therapeutics; Lilly (Inst); Novartis (Inst); Rna Diagnostics (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Tersera
Research Funding - AstraZeneca (Inst); Atossa Genetics (Inst); Lilly (Inst); Loxo (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Development of Human Tumor Xenografts from Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (Inst); Methods and Materials for Assessing Chemotherapy Responsiveness and Treating Cancer; METHODS AND MATERIALS FOR USING BUTYRYLCHOLINESTERASES TO TREAT CANCER
Travel, Accommodations, Expenses - Lilly (Inst)
 
Keith L. Knutson
Leadership - AffyImmune Therapeutics; Kiromic
Stock and Other Ownership Interests - Kiromic
Research Funding - Marker Therapeutics
Patents, Royalties, Other Intellectual Property - Mayo Clinic holds several patents of technologies that I have developed.